WindRose Health Investors
WindRose Health Investors is a healthcare-focused private equity firm investing principally in healthcare services and technology-enabled businesses that seek to improve quality, efficiency, and access.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier I
Overview
WindRose Health Investors is a healthcare-focused private equity firm investing principally in healthcare services and technology-enabled businesses that seek to improve quality, efficiency, and access. Its portfolio spans provider, payer, pharmaceutical, clinical, and administrative infrastructure.
The firm has expanded substantially while maintaining a sector-specific mandate. The closing of its seventh fund at $2.6 billion brought assets under management to approximately $7 billion, giving WindRose the capital base to pursue larger platforms while continuing to apply a focused healthcare-services model. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | WindRose Health Investors |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | New York, United States |
| Founded | 2000 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier I |
Activities and investment capabilities
WindRose has also developed a dedicated technology and artificial-intelligence capability to help portfolio companies identify and implement operational projects. This reflects the increasing need for healthcare investors to support data, automation, cloud, cybersecurity, and AI execution rather than treat technology as a purely external diligence topic.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
WindRose fits Tier I because it combines more than two decades of healthcare investing with current institutional scale, a clearly defined services strategy, and visible operating resources aligned with the direction of healthcare delivery.
WindRose Health Investors is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
WindRose Health Investors is recognized Tier I in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through WindRose Health Investors’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to WindRose Health Investors as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | WindRose Health Investors |
| Headquarters | New York, United States |
| Public website | windrose.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
